miR-342 suppresses the proliferation and invasion of acute myeloid leukemia by targeting Naa10p

被引:10
|
作者
Wang, Haiyan [1 ]
He, Heng [2 ]
Yang, Chunyan [1 ]
机构
[1] Jining Med Univ, Dept Hematol, Affiliated Hosp, 89 GuKui Rd, Jining 272029, Shandong, Peoples R China
[2] Jining Med Univ, Dept Digest Med, Affiliated Hosp, Jining, Shandong, Peoples R China
关键词
miR-342; Naa10p; AML; proliferation; DOWN-REGULATION; EXPRESSION; MIGRATION;
D O I
10.1080/21691401.2019.1596930
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Accumulating studies showed that microRNAs are maintaining a variety of important biological processes but the underlying mechanism in proliferation and tumourigenicity is unclear. In this study we show that miR-342 expression in bone marrow and patients' sera of childhood acute myeloid leukemia (AML) was both significantly higher than those in the corresponding normal controls. Functional assays demonstrated that forced expression of miR-342 significantly suppresses AML cell proliferation and G1/S transition of leukemia cells. Mechanistically, bioinformatics prediction and luciferase reporter assay identified N-a-acetyltransferase 10 protein (Naa10p) as a direct molecular target of miR-342, Naa10p siRNA significantly repressed cell proliferation and increased cell apoptosis. In conclusion, our study confirmed that miR-342/Naa10p plays key roles in AML progression, providing insights into underlying mechanisms of AML pathogenesis and also a potential therapeutic target for this malignancy.
引用
收藏
页码:3671 / 3676
页数:6
相关论文
共 50 条
  • [1] Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
    Hussein Fayyad-Kazan
    Nizar Bitar
    Mehdi Najar
    Philippe Lewalle
    Mohammad Fayyad-Kazan
    Rabih Badran
    Eva Hamade
    Ahmad Daher
    Nader Hussein
    Rim ELDirani
    Fadwa Berri
    Luc Vanhamme
    Arsène Burny
    Philippe Martiat
    Redouane Rouas
    Bassam Badran
    Journal of Translational Medicine, 11
  • [2] Circulating miR-150 and miR-342 in plasma are novel potential biomarkers for acute myeloid leukemia
    Fayyad-Kazan, Hussein
    Bitar, Nizar
    Najar, Mehdi
    Lewalle, Philippe
    Fayyad-Kazan, Mohammad
    Badran, Rabih
    Hamade, Eva
    Daher, Ahmad
    Hussein, Nader
    ElDirani, Rim
    Berri, Fadwa
    Vanhamme, Luc
    Burny, Arsene
    Martiat, Philippe
    Rouas, Redouane
    Badran, Bassam
    JOURNAL OF TRANSLATIONAL MEDICINE, 2013, 11
  • [3] miR-342 inhibits glioma cell proliferation by targeting GPRC5A
    Wang, Jianjiao
    Yang, Yan
    Cao, Yuandong
    Tang, Xinyu
    MOLECULAR MEDICINE REPORTS, 2019, 20 (01) : 252 - 260
  • [4] miR-342-3p Inhibits Acute Myeloid Leukemia Progression by Targeting SOX12
    Wang, Ying
    Guo, Xiaonan
    Wang, Lihua
    Xing, Lina
    Zhang, Xiaolei
    Ren, Jinhai
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2022, 2022
  • [5] miR-342-3p suppresses proliferation, migration and invasion by targeting FOXM1 in human cervical cancer
    Li, Xu-ri
    Chu, Hui-jun
    Lv, Teng
    Wang, Lei
    Kong, Shou-fang
    Dai, Shu-zhen
    FEBS LETTERS, 2014, 588 (17): : 3298 - 3307
  • [6] MiR-10b regulates the proliferation and apoptosis of pediatric acute myeloid leukemia through targeting HOXD10
    Wang, C-J
    Zou, H.
    Feng, G-F
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2018, 22 (21) : 7371 - 7378
  • [7] MiRNA-485-5p suppresses the proliferation of acute myeloid leukemia via targeting SALL4
    Wang, W-L
    Wang, H-R
    Ji, W-G
    Guo, S-L
    Li, H-X
    Xu, X-Y
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (11) : 4842 - 4849
  • [8] microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10
    Yang, Hongju
    Li, Qian
    Niu, Jie
    Li, Bai
    Jiang, Dejun
    Wan, Zhihua
    Yang, Qingmei
    Jiang, Fei
    Wei, Ping
    Bai, Song
    ONCOTARGET, 2016, 7 (03) : 2709 - 2720
  • [9] miR-1290 PROMOTES PROLIFERATION AND SUPPRESSES APOPTOSIS IN ACUTE MYELOID LEUKEMIA BY TARGETING FOXG1/SOCS3
    Sun, Y.
    Ju, X-L.
    Li, D.
    Zhou, P-P.
    Li, X.
    Luo, R-H.
    JOURNAL OF BIOLOGICAL REGULATORS AND HOMEOSTATIC AGENTS, 2019, 33 (06): : 1703 - 1713
  • [10] Retraction Note: Aberrant mannosylation profile and FTX/miR-342/ALG3-axis contribute to development of drug resistance in acute myeloid leukemia
    Bing Liu
    Xiaolu Ma
    Qianqian Liu
    Yang Xiao
    Shimeng Pan
    Li Jia
    Cell Death & Disease, 11